These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 12630981)
1. Planning and monitoring of placebo-controlled survival trials: comparison of the triangular test with usual interim analyses methods. Hulot JS; Cucherat M; Charlesworth A; Van Veldhuisen DJ; Corvol JC; Mallet A; Boissel JP; Hampton J; Lechat P Br J Clin Pharmacol; 2003 Mar; 55(3):299-306. PubMed ID: 12630981 [TBL] [Abstract][Full Text] [Related]
2. Implementation of group sequential logrank tests in a maximum duration trial. Lan KK; Lachin JM Biometrics; 1990 Sep; 46(3):759-70. PubMed ID: 2242413 [TBL] [Abstract][Full Text] [Related]
3. Trial Sequential Analysis in systematic reviews with meta-analysis. Wetterslev J; Jakobsen JC; Gluud C BMC Med Res Methodol; 2017 Mar; 17(1):39. PubMed ID: 28264661 [TBL] [Abstract][Full Text] [Related]
5. Quantifying the bias in the estimated treatment effect in randomized trials having interim analyses and a rule for early stopping for futility. Walter SD; Han H; Briel M; Guyatt GH Stat Med; 2017 Apr; 36(9):1506-1518. PubMed ID: 28183155 [TBL] [Abstract][Full Text] [Related]
11. Stopping clinical trials early for benefit: impact on estimation. Freidlin B; Korn EL Clin Trials; 2009 Apr; 6(2):119-25. PubMed ID: 19342463 [TBL] [Abstract][Full Text] [Related]
12. Information time scales for interim analyses of randomized clinical trials. Freidlin B; Othus M; Korn EL Clin Trials; 2016 Aug; 13(4):391-9. PubMed ID: 27136947 [TBL] [Abstract][Full Text] [Related]
13. Flexible implementations of group sequential stopping rules using constrained boundaries. Burington BE; Emerson SS Biometrics; 2003 Dec; 59(4):770-7. PubMed ID: 14969454 [TBL] [Abstract][Full Text] [Related]
14. Adaptive Designs with Discrete Test Statistics and Consideration of Overrunning. Schmidt R; Burkhardt B; Faldum A Methods Inf Med; 2015; 54(5):434-46. PubMed ID: 26429500 [TBL] [Abstract][Full Text] [Related]
15. Computations for group sequential boundaries using the Lan-DeMets spending function method. Reboussin DM; DeMets DL; Kim KM; Lan KK Control Clin Trials; 2000 Jun; 21(3):190-207. PubMed ID: 10822118 [TBL] [Abstract][Full Text] [Related]
17. Conditional power calculations for early acceptance of H0 embedded in sequential tests. Betensky RA Stat Med; 1997 Feb; 16(4):465-77. PubMed ID: 9044533 [TBL] [Abstract][Full Text] [Related]
18. Sample size adjustment based on promising interim results and its application in confirmatory clinical trials. Chen YH; Li C; Lan KK Clin Trials; 2015 Dec; 12(6):584-95. PubMed ID: 26195615 [TBL] [Abstract][Full Text] [Related]
19. A useful design utilizing the information fraction in a group sequential clinical trial with censored survival data. Hsu CY; Chen CH; Hsu KN; Lu YH Biometrics; 2019 Mar; 75(1):133-143. PubMed ID: 30004574 [TBL] [Abstract][Full Text] [Related]